- Impact of VM-20 on life insurance product development: Phase 2
By Paul M. Fedchak, Jacqueline M. Keating, Karen K. Rudolph, Uri Sobel, Andrew Steenman | 14 August 2017
Phase 2 of this research report expands on the Phase 1 case studies for term and universal life with secondary guarantees (ULSG) products and includes additional case studies focused on smaller companies and the impact of reinsurance.
- Pension Funding Index August 2017
By Charles J. Clark, Zorast Wadia | 10 August 2017
In July, the funded status of the 100 largest corporate defined benefit pension plans increased by $4 billion as measured by the Milliman 100 Pension Funding Index (PFI).
- Monthly Benefit News and Developments, August/September 2017
By Milliman Employee Benefits Research Group | 10 August 2017
Monthly benefits news and developments in the United States.
- Milliman FRM Market Commentary: July 2017
By Joe Becker | 08 August 2017
Markets in July climbed higher as volatility edged lower.
- Healthcare: It’s complicated
By Hans K. Leida, Lindsy Kotecki | 08 August 2017
Actuaries have had a front-row seat as healthcare reform has unfolded and are in a unique position to help address the challenges the complex system presents.
- Big data finally reveals how retirees really live
By Wade Matterson | 07 August 2017
Data is just one component of delivering a personalised retirement experience.
- Credit risk transfer: Investment comparison
By Rehan Siddique, Jonathan B. Glowacki | 07 August 2017
As the market for credit risk transfer transactions continues to grow and diversify, investors should continue to look to them as valuable parts of their portfolios and consider them as one way to participate in the mortgage market.
- 2017 U.S. organ and tissue transplant cost estimates and discussion
By T. Scott Bentley, Steve Phillips | 03 August 2017
This report is Milliman’s triennial summary of estimated U.S. average costs per member per month, billed charges, and utilization related to the 30 days prior and 180 days after transplant admission for organ and tissue transplants.
- 2016 Embedded Value Results: Asia (excl. Japan)
By Paul Sinnott, Michael Daly, Richard W. Holloway, Wing F. Wong, Chihong An | 02 August 2017
This report compares and contrasts the various different approaches taken to embedded value reporting across Asian markets and insurers.
- Obstacles for insurers of obstacle course racing
By Jenna Hildebrandt, Michael A. Henk | 02 August 2017
Obstacle course racing is sweeping the fitness and entertainment world alike, but is creating obstacles of its own for the insurance industry.